|
Feb 17
|
Why Johnson & Johnson (JNJ) Is One of the Best Drug Stocks to Buy Now
|
|
Feb 15
|
Dividend Investor With $1.05 Million In Stocks And $36,600 Annual Payout Shares Portfolio – 'Could These Picks Set You Up for Life?'
|
|
Feb 15
|
Johnson & Johnson (JNJ): Among the Best Forever Stocks to Buy Right Now
|
|
Feb 14
|
ROKU Q4 Loss Narrower Than Expected, Revenues Increase Y/Y
|
|
Feb 14
|
Jim Cramer on Johnson & Johnson (JNJ): ‘Too Slow Growing’
|
|
Feb 14
|
J&J’s High Hopes for Heart-Rhythm Device Grounded by Safety Concerns
|
|
Feb 13
|
Johnson & Johnson (NYSE:JNJ) Goes Ex-Dividend Soon
|
|
Feb 13
|
J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results
|
|
Feb 13
|
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
|
|
Feb 13
|
New nipocalimab data published in mAbs journal details differentiated molecular design, clinical profile and potential of nipocalimab to treat IgG-driven alloantibody and autoantibody diseases
|
|
Feb 13
|
Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead
|
|
Feb 13
|
Sanofi to take $250M charge on study failure for E. coli vaccine
|
|
Feb 12
|
Johnson & Johnson (JNJ): Jim Cramer on “The Greatest Health Care Stock of All Time”
|
|
Feb 12
|
Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy
|
|
Feb 12
|
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
|
|
Feb 11
|
Market Chatter: Johnson & Johnson Seeks to Sell Stroke Care Unit for More Than $1 Billion
|
|
Feb 11
|
Johnson & Johnson puts stroke care business up for sale
|
|
Feb 10
|
Are You Looking for a High-Growth Dividend Stock?
|
|
Jan 4
|
This Johnson & Johnson Insider Reduced Their Stake By 37%
|
|
Jan 3
|
The Descent of an Army Vet Turned Corporate Consultant Named in the New Year’s Attack
|